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Primary PCI is the treatment of choice for patients with STEMI since it results 
in greater patency of the infarct-related artery (IRA) and lower rates of re-infarc-
tion, stroke and death when compared with fibrinolysis alone1. Multivessel disease 
(MVD) occurs in 40% to 65% of patients with STEMI2. Is it possible for an aggressive 
multivessel percutaneous revascularization strategy may afford advantages in greater 
myocardial salvage and avoidance of staged procedures, with subsequent savings in 
compounded procedural risks.
Contemporary studies have produced controversial results. Previous retrospective 
non-randomized trials have shown that patients with STEMI who have undergone 
multivessel PCI have increased rates of re-infarction, need for revascularization2 
and stroke3. On the contrary a retrospective non-randomized trial and prospective 
randomized trial (with a small number of participants) have shown that patients with 
STEMI and multivessel PCI had similar incidence of death, re-infarction or target-
lesion revascularization (TLR) compared with those with primary PCI of the IRA 
alone during hospital stay and at 12 and 36 months4,5. Furthermore, data of a large 
New York registry have shown that patients with STEMI that had multivessel PCI 
had significantly lower rates of MACE during hospital stay6. Recently a prospective 
study has compared different revascularization strategies in patients presenting with 
STEMI: a. culprit vessel PCI alone, b. revascularization of culprit plus additional 
vessels at the time of primary PCI, c. staging a second PCI during the initial hospital 
stay, d. staging a second PCI within 60 days. Patients having culprit vessel PCI alone 
had lower mortality rates compared with those who had revascularization of culprit 
plus additional vessels at the time of primary PCI. The same study has shown that had 
a staged PCI within 60 days is the best revascularization stategy7. There is no doubt 
that total revascularization is the treatment of choice for patients with STEMI and 
cardiogenic shock. Data from SHOCK trial have shown that 30-day and 6-month mor-
tality is significantly lower in patients that had complete revascularizarion compared 
to those that received medical treatment only8.
It is evident that there are no sufficient and convincing evidence that support 
multivessel PCI in the setting of a STEMI. Despite the fact that staged PCI during 
hospital stay is feasible it does not offer any substantial benefit. It seems that staged 
PCI within 60 days of index event is the best revascularization strategy for patients 
with MVD and STEMI. On the other hand total revascularization is the treatment 
of choice for patients with STEMI and cardiogenic shock.
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